Maximus, Inc. $MMS Stock Position Decreased by Meeder Asset Management Inc.

Meeder Asset Management Inc. decreased its holdings in shares of Maximus, Inc. (NYSE:MMS) by 76.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,813 shares of the health services provider’s stock after selling 31,126 shares during the quarter. Meeder Asset Management Inc.’s holdings in Maximus were worth $897,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the business. Parkside Financial Bank & Trust grew its holdings in shares of Maximus by 21.7% during the second quarter. Parkside Financial Bank & Trust now owns 879 shares of the health services provider’s stock valued at $62,000 after purchasing an additional 157 shares during the last quarter. GAMMA Investing LLC boosted its position in Maximus by 13.9% during the 3rd quarter. GAMMA Investing LLC now owns 1,337 shares of the health services provider’s stock valued at $122,000 after purchasing an additional 163 shares during the period. Trust Point Inc. grew its stake in Maximus by 3.7% during the 3rd quarter. Trust Point Inc. now owns 5,286 shares of the health services provider’s stock worth $483,000 after buying an additional 191 shares during the last quarter. Verus Financial Partners Inc. grew its stake in Maximus by 6.7% during the 2nd quarter. Verus Financial Partners Inc. now owns 3,387 shares of the health services provider’s stock worth $244,000 after buying an additional 214 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Maximus by 0.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock worth $2,351,000 after buying an additional 221 shares during the period. Institutional investors own 97.21% of the company’s stock.

Maximus Price Performance

Shares of NYSE MMS opened at $96.63 on Tuesday. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $97.20. The firm’s 50-day simple moving average is $85.77 and its 200 day simple moving average is $83.53. The company has a quick ratio of 1.64, a current ratio of 1.64 and a debt-to-equity ratio of 0.77. The stock has a market cap of $5.26 billion, a P/E ratio of 17.38 and a beta of 0.56.

Maximus (NYSE:MMS) last announced its earnings results on Thursday, November 20th. The health services provider reported $1.62 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.01). The company had revenue of $1.32 billion during the quarter, compared to the consensus estimate of $1.34 billion. Maximus had a net margin of 5.87% and a return on equity of 25.23%. The business’s quarterly revenue was up .2% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.46 EPS. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. Equities analysts expect that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Investors of record on Friday, February 13th will be paid a dividend of $0.33 per share. This is a boost from Maximus’s previous quarterly dividend of $0.30. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date is Friday, February 13th. Maximus’s dividend payout ratio (DPR) is 21.58%.

Analysts Set New Price Targets

MMS has been the subject of several analyst reports. Zacks Research raised shares of Maximus from a “hold” rating to a “strong-buy” rating in a report on Tuesday, December 30th. Weiss Ratings reiterated a “buy (b-)” rating on shares of Maximus in a research report on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Strong Buy”.

Insider Buying and Selling

In related news, insider Michelle F. Link sold 4,039 shares of the business’s stock in a transaction that occurred on Wednesday, December 3rd. The stock was sold at an average price of $86.84, for a total transaction of $350,746.76. Following the sale, the insider owned 19,542 shares of the company’s stock, valued at $1,697,027.28. The trade was a 17.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.60% of the stock is currently owned by insiders.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.